Hearing Loss Trial, Recruiting NCT06040892 Sponsor: Hospices Civils de Lyon Condition: Hearing Loss
Back to Hearing Loss

Hearing Loss Trial, Recruiting

NCT06040892
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • The child must be between 7 and 17 years old
  • The child must have normal vision, with glasses or contact lenses if needed
  • The child must be able to understand the instructions given during the study
  • The child's parent or guardian must have been informed about the study and signed a consent form

For children with normal hearing only:

  • The child's hearing test results must show normal hearing levels (average hearing threshold of 30 dB or less)

For children with bilateral cochlear implants only:

  • The child must have had at least 2 years of experience using two cochlear implants together
  • The child must be able to recognise speech at an average rate of 80% or higher when using both cochlear implants

Who may not be able to join:

  • Children who have a complete loss of balance function in both ears
  • Children who have been diagnosed with an attention deficit disorder
  • Children who have a known neurological or psychiatric condition
  • Children who have a condition affecting eye movement control
  • Children whose parents or guardians are not affiliated with a social security scheme or an equivalent scheme that covers the child's participation
  • Children who are currently taking part in another interventional research study that has an exclusion period that has not yet ended

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Aurélie Coudert, MD, Hospices Civils de Lyon

Phone: 0427855506

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
27 March 2024
Est. completion
27 July 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

To evaluate the very short-term effects of spatial rehabilitation on the auditory performance of bCI children.; To evaluate the very short-term effects of spatial rehabilitation on the auditory performance of bCI children.; To evaluate the very short-term effects of spatial rehabilitation on the auditory performance of bCI children.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov